Posted on Authorea 30 Mar 2020 — CC BY 4.0 — https://doi.org/10.22541/au.158560473.38784736 — This a preprint and has not been peer reviewed. Data may be preliminary. prtrwohsmr hn2 er feprec nivsv nrueiepoeue.Tepoeuewas procedure The procedures. intrauterine invasive same in the by experience done of were years Hospital amnioinfusion) 20 Academy (transabdominal the than 2) procedures more and the has Qatar all – who However, Doha operator in Sudan. Hospital Women’s – 1) Khartoum centers, two in at oligohydramnios conducted with was study patients This of group this Methods: in trimesters. and used third Materials when and amnioinfusion second relieve the of to in benefit oligohydramnios present amnioinfusion the of with who intrapartum assess benefit women beneficial that to pregnant therapeutic is was proven for The compression study been treatment cord conservative diagnosis. has to recommends and it amniotic due (NICE) visualization However, of labor improve value in to debatable. normal distress is the very fetal it restore procedure is system, to this procedure lactate musculoskeletal of development. this ringer lung purpose the or fetal The saline of for normal development fluid. critical of debatable is and installation is and movement entails maturity forces Amnioinfusion fetal lung external fetal from for on fetus important growing trimesters the third also protects and is second literature fluid the the hypoplasia during in pulmonary Amniotic documented oligohydramnios Fetal well of death. is effect gestation neonatal early the and score in fetal oligohydramnios apgor to from compression, low leading results this cord which hypoplasia which and pulmonary outcomes as of distress, fetal perinatal such consequence adverse fetal is problems with complication restriction, the fetal associated growth also severe however, is intrauterine cause Oligohydramnios problem; include can deformity. antenatal limb Oligohydramnios and common prolapse serious. cord very very be a can not condition is oligohydramnios Significant of mode the Introduction: especially patients, of malformation management fetal safe. the very congenital on fetal concomitant impact be major the major to a a by of proven had complicated majority accuracy been accuracy were delivery. diagnosis in has diagnosis pregnancies the The these and procedure that as improved. chorioamnioitis The significantly showed surprising, of was not Conclusion: study was cases this days. which amnioinfusion. 5 Significantly, mortality 31 after were perinatal was malformation. made high There delivery weeks. was a and 24 showed diagnosis respectively. infusion was result final treatment 35%, first The first the the and the between cases, 45% interval at all the were however, mean age of centers; mortalities gestational The two mean neonatal in amnioinfusion. The and treated one Results: were Perinatal than patients pregnant more operator. The received same in patients 2016. the amnioinfusion Some treated by and transabdominal oligohydramnios 2011 performed of of between were cases outcome procedures 80 period involving the the the study evaluate in observational prospective to ultrasound, a was transabdominal is with This paper this Method: of oligohydramnios. with objective patients The Objective: Abstract: Abstract 2020 28, April 1 Ahmed Badreldeen membrane intact and patients oligohydramnios pregnant with in amnioinfusion transabdominal of Outcome ffiito o available not Affiliation 1 1 11 h ainlIsiueo lnclExcellence Clinical of Institute National The . 1,2,3 oee,tems serious most the However, . 12 ,5,6,7,8,9 4, h i fthis of aim The . However, . 10 . . Posted on Authorea 30 Mar 2020 — CC BY 4.0 — https://doi.org/10.22541/au.158560473.38784736 — This a preprint and has not been peer reviewed. Data may be preliminary. anyrpa eaendlvr n iouto hc r efre xesvl nti ato h world. the of part surgery, difficult this previous was to in anomaly due extensively tissue renal performed scar renal are of of presence bilateral which diagnosis the of liposuction The and cases and window delivery 10 acoustic disease. as Cesarean were kidney fluid There repeat of polycystic mainly lack renal. infantile BMI, was obstetricians high of observed of all patients. cases anomaly because by all structural 15 to performed fetal and setting. accessible main be outpatient agenesis easily the the can it study, at make and this will performed In needed This be equipment can procedures. invasive minimal and intrauterine with procedure in inexpensive safe trained a is The is procedure amnioinfusion 3). The (Table that respectively. days showed 35%, 4.3 study and was mean 45% This NICU low at of the a high weeks prematurity, in very days to 30 were of Due group - Discussion number this 2). 28 average (Table in delivered between The mortalities gestation delivered cases recorded. neonatal of was cases and weeks All general kg prenatal 14 31 under 1.4 after gestation, 3). of placenta delivered (Table of weight of cases birth weeks hemorrhage removal 4 done 28 manual only postpartum was needed and before mild indication gestation group delivered and obstetrics delivery cases placenta vaginal for 22 retained the prematurely, delivery cases). of in Caesarean (68 patients because vaginally Elective Two delivered anesthesia group delivery. cases. this forceps mostly 12 in from death by patients in fetal mainly of delivered intrauterine scarring of Majority cases surgical cases diagnosis malformation. 26 Three and were The structural BMI There fetal cases. high 1). with 18 had (Figure fetuses in liposuction patients and amnioinfusion infantile the of delivery and after caesarean two because agenesis only fetal previous amnioinfusion renal procedure, of confirmed before bilateral cases was the with 52 impossible diagnosis were of diagnosed was The there cases weeks group, disease. 25 two study were insertion. kidney none the within There needle polycystic In and chorioamnionitis 1). second membrane. patients (Table pregnancy of of a malformation the during rupture signs needed structural spontaneous pressure in case developed developed controlled blood cases no which five high properly and cases these of was uncomplicated 5 cases Hypertension mellitus was were four diabetes procedure methyldopa. There were gestational The of There of incidence form preeclampsia. cases). The uterine in developed (18 3 4. hemorrhage, medication found 22.5% later chromosome We as on about abnormal a anomaly. such all was of structural at case procedure group fetal chorioamnionitis apparent one this the developed (range no and in of cases was weeks 21 there Five time trisomy 28.5 when of was the only 2). the cases delivery at (Table performed of at was encountered abruption time age Amniocentesis were the and gestational stage. events at trauma, the age adverse organ However, this gestational in No fetal mean 33). cases irritability, the The – 39). had All 18 2). – study 1). (Table obese (range (Table 20 trimesters and weeks the group overweight third 25.5 the in of and of was During incidence included 25% second procedure The almost the cases operator. compromising in cm. high, All presented same 1.8 was cohort being group the administered. study pool by this were deepest guidance in average patients tocolytics ultrasound the or with direct oligohydramnios anesthesia under severe local amnioinfusion received no cases amnioinfusion, 80 the All outcome. vertical neonatal deepest and presentation, fetal at delivery, previous Result: age of to gestational mode BMI, due patient, parity, adhesion every age, for and maternal difficult pool BMI was data: examination following high the The liquor, collected guidance. liposuction). reduced We specialist. and was US of medicine scars and direct because fetal section SROM under a cases caesarean confirms by (mainly needle of which details surgery amniocentesis majority liquor great procedure in using of in the nonconclusive pool done examined during and a was were examination of fluid fetuses Amnioinfusion presence vaginal of the the loss by or study. All canal experienced done the cervical patient was the from study One from examined entire excluded This leaking were the vagina. liquor (SROM). patients for for the membrane the search recorded in in all of was speculum procedure, centimeters rupture sterile the 3 a spontaneous to using than prophylaxis. Prior exclude less antibiotic oligohydramnios. to of received of (DVP) patients clinically diagnosis the pool the All vertical confirming deepest obtained. group, was that consent found verbal was and It patients the to explained 2 Posted on Authorea 30 Mar 2020 — CC BY 4.0 — https://doi.org/10.22541/au.158560473.38784736 — This a preprint and has not been peer reviewed. Data may be preliminary. -W S hnC,Co C umnr yolsaIdcdb lghdano:Fnig rmAnimal from Findings Oligohydramnios: by Study. Induced Population-Based Hypoplasia a Pulmonary HC. and Chou Models CM, Chen CS, Wu 4- Short A. Maayan-Metzger A, 2012;101(7):727- Weissmann-Brenner intrapartumoligohydramnios.ActaPaediatr. with I, 30 infants Schushan-Eisen singleton 793-98. term E, 44(7): among outcome 2016; Rosenfeld term Med. J, Perinat Kuint J L, pregnancy. 3-Leibovitch term at oligohydramnios JL.Perinatal Vallejo isolated [4] Gallo with of FM, Ventoso outcomes MP, prediction Badillo and BJOG. Ru´ız Carrillo A, Association RS, meta-analysis. PuertasPrieto M, al. 2-.Naveiro-Fuentes and et review MD, Systematic Kilby 686-99. outcome: RD, pregnancy 121(6): Riley adverse 2014; GM, for Malin measurements J, Tamblyn fluid CH, amniotic Meller RK, Morris 1- study. References: this for funding or grant No obtained approval ethical No Funding amnioinfusion. before consent gave patients All approval ethics author of the Details by done are procedures the study observational All this to regard authorship with to interests Contribution of conflict no declare authors The serious with delivery interests operative of of chance Disclosure the decreases life. and with delivery family. of compatible the mode not consequences. of the malformation counseling influences major facilitating information a and This have diagnosis cases final these the of making Majority of in 3) critical lack very The is inexpensive. procedure not and with The cases. conclude simple and 2) can safe, of study we very shortage However, observational is criticized. the procedure longitudinal be The to a can 1) due babies is born it difficult live that on be effect following: fact will term the the long randomization the in However, about reflected information is trial. study randomized right this a the of of at group limitation done a was The be it could if maturity there lung oligohydramnios, improve Conclusion: line to border mainly a amnioinfusion and investigators age from other malformation gestational benefit many the fetal by may debated in major who been rate, even of patients have delivery findings such that absence operative These high complications showed the restriction, many admission. study In growth NICU with intrauterine morbidity Our and severe associated score as labour, is Apgar deliveries. preterm another such oligohydramnios low early cesarean and of complication of family chance presence repeat serious higher large the multiple more as, malformation, a of a have fetal result contracting to of a tend absence of avoid obstetri- patients chance as to advise world, as the placenta, We the so adherent increase of indication, life. may part maternal with delivery for this incompatible caesarean except In after is intervention dramatically delivery. avoid which improved operative and anomaly parents monitoring unnecessary fetal intrapartum of serious avoid Counseling to this cians of amnioinfusion. diagnosis after the only confirming confirmed was diagnosis The 16 . PediatrNeonatol 3 2017; 58 –7. 3– : 13,14,15 . Posted on Authorea 30 Mar 2020 — CC BY 4.0 — https://doi.org/10.22541/au.158560473.38784736 — This a preprint and has not been peer reviewed. Data may be preliminary. membrane outcome-of-transabdominal-amnioinfusion-in-pregnant-patients-with-oligohydramnios-and-intact- amnioinfusion.pptx Antenatal file Hosted transabdominal-amnioinfusion-in-pregnant-patients-with-oligohydramnios-and-intact-membrane Tables.docx EDITED pregnancies file 2002;76:15–21. Fetal preterm Hosted GynaecolObstet to in J Relation transabdominalamnioinfusion Int Its prophylactic oligohydramnios. and Antepartum by Index N. complicated Atacan Fluid NO, Amniotic 33:705–711 Turhan Borderline 2014; 16. Med K. Ultrasound Lesser J L, Wang Labor. JM, pregnancy. of term Newton Intolerance uncomplicated SL, the 457-460. Wood, in 29: outcomes 15. 2016; perinatal Med and Neonatal index fluid Fetal fluid amniotic Matern amniotic normal J Borderline versus 705-710. SR. borderline Choi 11: with 2013; 14. pregnancies Med of Reprod outcomes J Perinatal Iran R. index. faraji M, Asgharnia 13. labour).November 1-84629-300-6. (excluding pregnancy ISBN oligohydramniosduring 2006; for amnioinfusion Therapeutic Excellence UK. Clinical – (NICE) and 1985;153:301-6. Health for Gynecol. Institute Obstet National J variable Am 12. repetitive study. of randomized relief prospective peripartum for A and amnioinfusion decelerations. index Saline fluid F. amniotic Nevarez, marginal FS, or Miyazaki Borderline 11. al. 2011;30:523–8. et Med WC, Ultrasound Hitt growth. J SP, lung Chauhan outcomes. fetal EF, on Magann forces - mechanical 10 of effects The JA. growth. Kitterman of lung 9- Effects fetal JA. in Kitterman sheep. factors S, fetal Physiological Hawgood in JA. LG, lung Kitterman Dobbs the 8- VK, of Han maturation L, and Allen growth CH, oligohydram- on Lee in factors CJ, mechanical Chapin pressure LD, amniotic Wallen hypoplasia? P, Low pulmonary Joe JS. 7- of Wigglesworth cause DG, the Talbert this CH, and is Rodeck hypoplasia NM, nios: analysis. pulmonary Fisk critical U, Neonatal a Nicolini D. 6- membranes: Mostello amniotic JB, of Shumway rupture TL, midtrimester Leet with ObstetGynecol E, patients Amon in mortality M, perinatal Chen HN, Winn 5- 2000; 182 vial at available 68 1644. 1638– : https://authorea.com/users/307163/articles/438118-outcome-of- vial at available https://authorea.com/users/307163/articles/438118- mJObstetGynecol J Am 4 a PhysiolPharmacol J Can 1989; mJPhysiol J Am ClinPerinatol 161 08 1101. 1098– : 1988; 1997; 1996; 66 272 23 12 1128. 1122– : 9–105. L95– : 2–740. 727– : mJ Am